Abbott Laboratories Return on Investment 2010-2024 | ABT

Current and historical return on investment (ROI) values for Abbott Laboratories (ABT) over the last 10 years.
Abbott Laboratories ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-09-30 $6.69B $52.85B 12.77%
2024-06-30 $6.48B $52.70B 12.41%
2024-03-31 $6.36B $51.62B 12.21%
2023-12-31 $6.48B $52.43B 12.43%
2023-09-30 $6.00B $52.17B 11.58%
2023-06-30 $6.13B $51.97B 11.87%
2023-03-31 $6.96B $51.85B 13.39%
2022-12-31 $8.36B $51.43B 16.02%
2022-09-30 $9.44B $51.18B 17.91%
2022-06-30 $10.21B $53.47B 19.31%
2022-03-31 $9.23B $52.72B 17.60%
2021-12-31 $8.43B $53.32B 16.18%
2021-09-30 $8.48B $52.08B 16.43%
2021-06-30 $7.43B $51.58B 14.54%
2021-03-31 $6.71B $51.28B 13.30%
2020-12-31 $5.36B $51.53B 10.84%
2020-09-30 $4.31B $49.94B 8.89%
2020-06-30 $4.02B $48.98B 8.29%
2020-03-31 $4.55B $47.23B 9.30%
2019-12-31 $4.53B $47.96B 9.13%
2019-09-30 $4.31B $49.66B 8.59%
2019-06-30 $4.11B $50.88B 8.16%
2019-03-31 $3.78B $49.97B 7.53%
2018-12-31 $3.65B $50.08B 7.17%
2018-09-30 $3.14B $50.18B 5.92%
2018-06-30 $2.91B $50.60B 5.36%
2018-03-31 $2.41B $52.76B 4.35%
2017-12-31 $1.56B $58.31B 2.78%
2017-09-30 $1.70B $55.53B 3.28%
2017-06-30 $1.83B $55.60B 4.09%
2017-03-31 $2.26B $55.31B 6.01%
2016-12-31 $3.03B $41.40B 9.93%
2016-09-30 $3.05B $26.87B 11.34%
2016-06-30 $2.87B $26.81B 10.62%
2016-03-31 $2.78B $26.82B 10.10%
2015-12-31 $2.87B $27.20B 10.31%
2015-09-30 $2.88B $27.17B 10.56%
2015-06-30 $2.90B $28.99B 10.66%
2015-03-31 $2.84B $27.92B 10.65%
2014-12-31 $2.60B $25.03B 9.83%
2014-09-30 $2.19B $26.71B 8.00%
2014-06-30 $1.93B $27.11B 7.04%
2014-03-31 $1.88B $26.88B 6.94%
2013-12-31 $2.13B $28.66B 7.91%
2013-09-30 $1.69B $27.19B 5.45%
2013-06-30 $1.53B $25.84B 4.50%
2013-03-31 $1.47B $26.15B 3.99%
2012-12-31 $1.36B $44.90B 3.44%
2012-09-30 $3.47B $39.16B 9.26%
2012-06-30 $3.75B $36.58B 10.11%
2012-03-31 $4.96B $37.41B 13.15%
2011-12-31 $5.75B $36.57B 15.26%
2011-09-30 $5.50B $37.79B 14.72%
2011-06-30 $6.09B $39.10B 16.67%
2011-03-31 $5.92B $37.25B 16.96%
2010-12-31 $6.09B $35.29B 18.15%
2010-09-30 $6.12B $34.39B 18.36%
2010-06-30 $6.58B $32.61B 19.95%
2010-03-31 $6.65B $31.89B 20.35%
2009-12-31 $6.24B $34.45B 19.43%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $198.127B $40.109B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Stryker (SYK) United States $138.991B 31.32
Boston Scientific (BSX) United States $131.097B 37.69
EssilorLuxottica (ESLOY) France $109.895B 0.00
Medtronic (MDT) Ireland $103.904B 15.43
Haleon (HLN) United Kingdom $43.864B 28.50
Lonza Group Ag (LZAGY) Switzerland $42.859B 0.00
GE HealthCare Technologies (GEHC) United States $36.052B 18.70
ResMed (RMD) United States $34.830B 28.62
Terumo (TRUMY) Japan $28.875B 0.00
Koninklijke Philips (PHG) Netherlands $23.602B 18.07
Zimmer Biomet Holdings (ZBH) United States $21.325B 13.58
Insulet (PODD) United States $18.698B 74.46
Baxter (BAX) United States $15.062B 9.80
Smith & Nephew SNATS (SNN) United Kingdom $10.781B 0.00
BellRing Brands (BRBR) United States $9.800B 39.43
Bio-Rad Laboratories (BIO) United States $9.168B 31.16
Demant (WILYY) Denmark $7.926B 0.00
Lantheus Holdings (LNTH) United States $6.208B 14.42
Prestige Consumer Healthcare (PBH) United States $3.889B 19.34
ICU Medical (ICUI) United States $3.840B 36.56
Haemonetics (HAE) United States $3.789B 18.49
Perrigo (PRGO) Ireland $3.513B 10.34
Envista Holdings (NVST) United States $3.218B 23.97
QuidelOrtho (QDEL) United States $3.016B 19.41
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.864B 18.36
Neogen (NEOG) United States $2.609B 30.10
LeMaitre Vascular (LMAT) United States $2.071B 50.34
Green Thumb Industries (GTBIF) United States $1.678B 29.37
AtriCure (ATRC) United States $1.498B 0.00
InMode (INMD) Israel $1.434B 8.63
AdaptHealth (AHCO) United States $1.383B 9.88
Maravai LifeSciences Holdings (MRVI) United States $1.356B 0.00
BioLife Solutions (BLFS) United States $1.271B 0.00
Curaleaf Holdings (CURLF) Canada $0.968B 0.00
Owens & Minor (OMI) United States $0.965B 7.54
CeriBell (CBLL) United States $0.964B 0.00
Phibro Animal Health (PAHC) United States $0.879B 15.49
Evolus (EOLS) United States $0.690B 0.00
Omeros (OMER) United States $0.597B 0.00
Capricor Therapeutics (CAPR) United States $0.594B 0.00
VAREX IMAGING (VREX) United States $0.584B 25.75
Surmodics (SRDX) United States $0.568B 0.00
Verano Holdings (VRNOF) United States $0.452B 0.00
Cresco Labs (CRLBF) United States $0.439B 0.00
Quanterix (QTRX) United States $0.403B 0.00
ZimVie (ZIMV) United States $0.375B 31.63
Biote (BTMD) United States $0.331B 7.26
Valneva SE (VALN) France $0.324B 0.00
Viemed Healthcare (VMD) United States $0.311B 29.56
Canopy Growth (CGC) Canada $0.308B 0.00
Sanara MedTech (SMTI) United States $0.294B 0.00
Cerus (CERS) United States $0.293B 0.00
OraSure Technologies (OSUR) United States $0.272B 18.20
Zynex (ZYXI) United States $0.263B 55.00
High Tide (HITI) Canada $0.242B 100.33
Aurora Cannabis (ACB) Canada $0.234B 0.00
Utah Medical Products (UTMD) United States $0.207B 14.29
Sanuwave Health (SNWV) United States $0.201B 2.82
MacroGenics (MGNX) United States $0.200B 0.00
Organigram Holdings (OGI) Canada $0.197B 0.00
TerrAscend (TSNDF) Canada $0.190B 0.00
Brainsway (BWAY) Israel $0.174B 92.40
FitLife Brands (FTLF) United States $0.145B 18.17
Jin Medical (ZJYL) China $0.133B 0.00
TriSalus Life Sciences (TLSI) United States $0.124B 0.00
Quipt Home Medical (QIPT) United States $0.107B 0.00
Fonar (FONR) United States $0.096B 10.81
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
Veru (VERU) United States $0.095B 0.00
Exagen (XGN) United States $0.091B 0.00
InterCure (INCR) Israel $0.068B 0.00
Rockwell Medical (RMTI) United States $0.067B 34.67
Apyx Medical (APYX) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.056B 0.00
Ayr Wellness (AYRWF) United States $0.051B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
Modular Medical (MODD) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Allurion Technologies (ALUR) United States $0.023B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.74
SNDL (SNDL) Canada $0.000B 0.00